Seguir
M L Go
M L Go
Dirección de correo verificada de nus.edu.sg
Título
Citado por
Citado por
Año
Chalcones: an update on cytotoxic and chemoprotective properties
ML Go, X Wu, XL Liu
Current medicinal chemistry 12 (4), 483-499, 2005
8722005
Antimalarial alkoxylated and hydroxylated chalones: structure− activity relationship analysis
M Liu, P Wilairat, ML Go
Journal of Medicinal Chemistry 44 (25), 4443-4452, 2001
6632001
Structure–activity relationships of antileishmanial and antimalarial chalcones
M Liu, P Wilairat, SL Croft, ALC Tan, ML Go
Bioorganic & medicinal chemistry 11 (13), 2729-2738, 2003
3732003
Antimalarial activity of ferrocenyl chalcones
X Wu, P Wilairat, ML Go
Bioorganic & medicinal chemistry letters 12 (17), 2299-2302, 2002
2692002
In-Silico Approaches to Multi-target Drug Discovery: Computer Aided Multi-target Drug Design, Multi-target Virtual Screening
XH Ma, Z Shi, C Tan, Y Jiang, ML Go, BC Low, YZ Chen
Pharmaceutical research 27, 739-749, 2010
1892010
Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene
X Wu, ERT Tiekink, I Kostetski, N Kocherginsky, ALC Tan, SB Khoo, ...
european journal of pharmaceutical sciences 27 (2-3), 175-187, 2006
1572006
Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus
XL Liu, YJ Xu, ML Go
European journal of medicinal chemistry 43 (8), 1681-1687, 2008
1452008
Antiplasmodial Chalcones Inhibit Sorbitol-Induced Hemolysis of Plasmodium falciparum-Infected Erythrocytes
ML Go, M Liu, P Wilairat, PJ Rosenthal, KJ Saliba, K Kirk
Antimicrobial Agents and Chemotherapy 48 (9), 3241-3245, 2004
1452004
Functionalized 3-benzylidene-indolin-2-ones: Inducers of NAD (P) H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity
W Zhang, ML Go
Bioorganic & medicinal chemistry 17 (5), 2077-2090, 2009
1352009
A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells*♦
M Wang, W Tan, J Zhou, J Leow, M Go, HS Lee, PJ Casey
Journal of biological chemistry 283 (27), 18678-18684, 2008
1312008
Functionalized aurones as inducers of NAD (P) H: quinone oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: synthesis, evaluation and SAR
CY Lee, EH Chew, ML Go
European journal of medicinal chemistry 45 (7), 2957-2971, 2010
1212010
Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein
XL Liu, HW Tee, ML Go
Bioorganic & medicinal chemistry 16 (1), 171-180, 2008
1112008
Antiproliferative properties of piperidinylchalcones
X Liu, ML Go
Bioorganic & medicinal chemistry 14 (1), 153-163, 2006
1072006
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)
HM Sim, CY Lee, PLR Ee, ML Go
European Journal of Pharmaceutical Sciences 35 (4), 293-306, 2008
1052008
Synthesis and evaluation of functionalized isoindigos as antiproliferative agents
XK Wee, WK Yeo, B Zhang, VBC Tan, KM Lim, TE Tay, ML Go
Bioorganic & medicinal chemistry 17 (21), 7562-7571, 2009
992009
Novel antiplasmodial agents
ML Go
Medicinal research reviews 23 (4), 456-487, 2003
942003
Aurones as modulators of ABCG2 and ABCB1: synthesis and structure–activity relationships
HM Sim, KY Loh, WK Yeo, CY Lee, ML Go
ChemMedChem 6 (4), 713-724, 2011
862011
Amphiphilic indole derivatives as antimycobacterial agents: structure–activity relationships and membrane targeting properties
T Yang, W Moreira, SA Nyantakyi, H Chen, DB Aziz, ML Go, T Dick
Journal of medicinal chemistry 60 (7), 2745-2763, 2017
852017
Caffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrine
LY Lim, ML Go
European Journal of Pharmaceutical Sciences 10 (1), 17-28, 2000
802000
Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines
XH Ma, R Wang, CY Tan, YY Jiang, T Lu, HB Rao, XY Li, ML Go, BC Low, ...
Molecular pharmaceutics 7 (5), 1545-1560, 2010
752010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20